Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study. - Wikidata - wikimedia - TriplyDB

Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study.

Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study.

http://www.wikidata.org/entity/Q33984272

about

Association between prenatal exposure to antiretroviral therapy and birth defects: an analysis of the French perinatal cohort study (ANRS CO1/CO11)EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associations Neurotoxic effects of AZT on developing and adult neurogenesis Antiretroviral therapy, pregnancy, and birth defects: a discussion on the updated data.Congenital anomalies and in utero antiretroviral exposure in human immunodeficiency virus-exposed uninfected infants Birth defects in a cohort of infants born to HIV-infected women in Spain, 2000-2009.CLEFT PALATE IN HIV-EXPOSED NEWBORNS OF MOTHERS ON HIGHLY ACTIVE ANTIRETROVIRAL THERAPY.First trimester exposure to antiretroviral therapy and risk of birth defects Prevalence of congenital anomalies in infants with in utero exposure to antiretrovirals Infant outcomes after maternal antiretroviral exposure in resource-limited settings.The NICHD International Site Development Initiative perinatal cohorts (2002-09)Zidovudine use in pregnancy and congenital malformations.Laboratory Abnormalities Among HIV-Exposed, Uninfected Infants: IMPAACT Protocol P1025 Antiretroviral use during pregnancy for treatment or prophylaxis.British HIV Association guidelines for the management of HIV infection in pregnant women 2012 (2014 interim review).Birth defects in a national cohort of pregnant women with HIV infection in Italy, 2001-2011.British HIV Association guidelines for the management of HIV infection in pregnant women 2012

P2860

Q28538279-87E89D36-75EE-4214-B442-D7AFDAE5CDC7 Q28817912-5013C069-BA94-45E7-8D8D-7CF096B20C63 Q30414740-8E13EEDF-FDD4-4B43-B5A2-928F36298053 Q30661395-F263EE14-DF61-4F44-AB93-9A0497CBEB83 Q34860149-A8281CBC-0B27-45EA-8365-16B616971AC2 Q34979228-E542433F-A8D3-4662-BDCD-1D1A1821408B Q35038144-A602EDD3-F5B8-4B6D-850F-F9FB1D2E25FF Q35572618-3F8CBD61-B004-4A31-B1FB-24FA671258E4 Q35680819-10957AE2-0F8A-4D71-B64E-F45A2D6ED8ED Q35996783-00F37505-B723-4A05-8462-40DF0FBDC5FD Q36093757-07162F7F-D696-4202-955A-64217763C35A Q36379162-7288D3AA-4BA1-4370-965F-87DCA7610AEF Q36851168-38E1592A-AE44-4A3D-B0D7-9627E128B323 Q37870932-04057BD7-A01A-4480-8FCD-E489F67C8BB8 Q38325427-BCC4EB40-6F0C-49F6-8130-3B09896158C2 Q42260917-761C0347-2B37-4A9C-8C75-57ED9219D54C Q57076282-8AF244FB-6334-4086-94AC-135AD75AE753

P2860

Maternal antiretroviral use during pregnancy and infant congenital anomalies: the NISDI perinatal study.

http://www.wikidata.org/entity/Q33984272

description

2010 nî lūn-bûn

@nan

2010 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Maternal antiretroviral use du ...... es: the NISDI perinatal study.

@ast

Maternal antiretroviral use du ...... es: the NISDI perinatal study.

@en

type

label

Maternal antiretroviral use du ...... es: the NISDI perinatal study.

@ast

Maternal antiretroviral use du ...... es: the NISDI perinatal study.

@en

prefLabel

Maternal antiretroviral use du ...... es: the NISDI perinatal study.

@ast

Maternal antiretroviral use du ...... es: the NISDI perinatal study.

@en

P1433

Q33984272-4ED29A56-D765-48EB-A54B-6482786EA9FD

P1476

Q33984272-9F9B55B1-EF80-4683-AB0F-A172AF81CBFB

P2093

Q33984272-143328A1-3801-4615-ACC5-2E0FD1E64378

Q33984272-1CF35A7E-2021-4BF2-BD47-DB185DCB9C28

Q33984272-390D8D37-3248-41A5-B253-9A338B032BA1

Q33984272-6E4D5E4A-803F-4C94-B18F-B0A27D4A0CBF

Q33984272-7002CFAD-3313-4886-9C69-31E45A8808C5

Q33984272-7C61D8A6-EF42-4A88-9625-4853757E71B4

Q33984272-7D417288-F61D-4770-9660-37F41C36B8E5

Q33984272-9EB7F604-042C-49DF-B674-E632704376CC

Q33984272-CFC7BD1B-6762-4361-B2D9-238A3293C0F7

Q33984272-F465EBFE-1C36-433E-9F01-9704B6F4CD4F

P2860

Q33984272-04DD08D2-FB8A-491C-9B5F-6E7A9A209D24

Q33984272-0EB88B70-8AC0-4486-945F-307842087B59

Q33984272-1E0C7565-0737-4141-AF6D-5AB1C30CD4D4

Q33984272-20BD91B3-07D7-4D74-A357-A4317E8E2CE9

Q33984272-2F2D6219-CE20-4A80-8BE1-59C6DEF05D63

Q33984272-3127919D-A91D-46A9-BA7F-8E2CA63764F1

Q33984272-370E01BA-79FE-4278-80A5-E81B22C42F39

Q33984272-420D7B84-F119-4702-B5DF-FA9BCEF78AAB

Q33984272-461BFA84-D1EA-4F96-A8C5-D25064E612B8

Q33984272-56BEF90A-AE35-479A-8CBF-1CA804C4A17E

P304

Q33984272-3FD0EB97-2273-473F-B334-95A78DAC7492

P31

Q33984272-07B8A492-35C9-4F02-ABBA-414BAB16265F

P356

Q33984272-059F1E15-F7F9-4E55-976F-41D38EFD58D8

P407

Q33984272-ED68B764-A8C4-4632-A323-FBE52916827E

P433

Q33984272-1F55D411-DC0E-409D-BECA-1DA6F9EDD316

P478

Q33984272-32841349-2248-44B7-8B71-D080F3256C3E

P50

Q33984272-BA4C0B73-0557-4350-AE0D-2507CF0DA33A

P577

Q33984272-0C20EA25-E296-4C1E-816F-7945BB7338AF

P5875

Q33984272-952276CE-6D17-4EA6-99A3-5511E5AF877A

P698

Q33984272-CD15A74A-363F-415B-85B6-FE9110942332

P921

Q33984272-C3CFA9DA-74A4-47C0-8904-FF6A1CC1C734

Q33984272-D5DF5480-DF69-4293-A333-9C77E46496F3

P932

Q33984272-46A8E63C-0633-4F79-9EFB-A5DB21060A31

P356

QAI.0B013E3181C5C81F

P1433

Journal of Acquired Immune Deficiency Syndromes

P1476

Maternal antiretroviral use du ...... es: the NISDI perinatal study.

@en

P2093

D Heather Watts

http://www.w3.org/2001/XMLSchema#string

Esau C Joao

http://www.w3.org/2001/XMLSchema#string

Javier Ortiz

http://www.w3.org/2001/XMLSchema#string

Jennifer S Read

http://www.w3.org/2001/XMLSchema#string

Laura Freimanis Hance

http://www.w3.org/2001/XMLSchema#string

Margot R Krauss

http://www.w3.org/2001/XMLSchema#string

Mary Reyes

http://www.w3.org/2001/XMLSchema#string

NISDI Perinatal Study Group

http://www.w3.org/2001/XMLSchema#string

Russell Pierre

http://www.w3.org/2001/XMLSchema#string

Silvina A Ivalo

http://www.w3.org/2001/XMLSchema#string

P2860

1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults

Is first trimester exposure to the combination of antiretroviral therapy and folate antagonists a risk factor for congenital abnormalities?

Folic acid antagonists during pregnancy and the risk of birth defects.

New Ballard Score, expanded to include extremely premature infants.

Folic acid supplementation and the occurrence of congenital heart defects, orofacial clefts, multiple births, and miscarriage.

Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis.

Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?

Management of human immunodeficiency virus-infected pregnant women at Latin American and Caribbean sites.

Antiretroviral therapy and congenital abnormalities in infants born to HIV-infected women in the UK and Ireland, 1990-2007.

Stillbirth rate and associated risk factors among 869 750 Latin American hospital births 1982-1986.

P304

176-185

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/QAI.0B013E3181C5C81F

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

53

http://www.w3.org/2001/XMLSchema#string

P50

Guilherme Calvet

P577

2010-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

41149092

http://www.w3.org/2001/XMLSchema#string

P698

20104119

http://www.w3.org/2001/XMLSchema#string

P921

antiretroviral drug

P932

2901917

http://www.w3.org/2001/XMLSchema#string